SPOTLIGHT -
Slideshow
Author(s):
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Why We Need a New Class of Antidepressants
Blue Light Blockers: A Behavior Therapy for Mania
Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD
Blue Light, Depression, and Bipolar Disorder
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder
Major Depressive Disorder Research Roundup